| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |